IM CANNABIS
IM Cannabis produces and distributes medical cannabis. Its products include products for patients and offer research and development of new genetic strains. Oren Shuster and Rafael Gabay founded IM cannabis in Glil Yam, Tel Aviv in 2010.
IM CANNABIS
Industry:
Cannabis Medical Pharmaceutical
Founded:
2010-01-01
Address:
Glil Yam, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.imcannabis.com
Total Employee:
11+
Status:
Active
Contact:
+972 77-444-2333
Email Addresses:
[email protected]
Total Funding:
20.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aphria
Aphria is a Canada-based company committed to providing accessible medical cannabis.
Bluma Wellness
Bluma Wellness cultivates, processes, and distributes cannabis for medical purposes.
Demecan
Demecan is a producer of medical cannabis.
Glacier Cannabis
Glacier Cannabis offers premium small-batch craft cannabis for medical and adult use.
Tetra Bio-Pharma
Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug development for inflammation, pain, and more.
Heilala Vanilla
Heilala Vanilla produces, and supplies vanilla beans.
Hemp Horizons
Cannabis and Hemp company
Holistic Industries
Holistic Industries is an organic medical cannabis company that provides cannabis-based medications.
Indiva
Indiva provide access to medical cannabis.
Kanabo
Kanabo is creating a new standard in the medical cannabis industry by building an ecosystem.
Leafline Labs
LeafLine Labs provides high quality medical cannabis and care to patients.
Little Green Pharma
Little Green Pharma produces a range of Medicinal Cannabis.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
MedCann
MedCann is an importer, manufacturer and distributor of medical cannabis.
Medical Marijuana Inc.
A Publicly Traded Holding Company
MedReleaf
MedReleaf is a Canadian licensed producer and distributor of medical cannabis.
National Tobacco Enterprise
National Tobacco Enterprise produces and distributes tobacco products.
Nuvista Pharma
Nuvista Pharma manufactures hormones and steroid drugs.
Tikun Olam
Tikun Olam is a supplier of medical cannabis.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
VIVO Cannabis Inc.
VIVO Cannabis manufactures and distributes cannabis.
Yitai Pharma
Yitai Pharma is an API and food additive manufacturer.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-03-30 | Oranim Pharm | Oranim Pharm acquired by IM Cannabis | N/A |
| 2021-04-01 | MYM Nutraceuticals | MYM Nutraceuticals acquired by IM Cannabis | 87 M USD |
| 2020-12-30 | Trichome Financial | Trichome Financial acquired by IM Cannabis | N/A |
Investors List
Marc Lustig
Marc Lustig investment in Post-IPO Equity - IM Cannabis
Oren Shuster
Oren Shuster investment in Post-IPO Equity - IM Cannabis
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-18 | Israeli cannabis company IMC Holdings appoints Rinat Efrima as CEO |
Official Site Inspections
http://www.imcannabis.com Semrush global rank: 5.03 M Semrush visits lastest month: 1.65 K
- Host name: 104.21.112.1
- IP address: 104.21.112.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "IM Cannabis"
IM Cannabis Announces Additional Restructuring Initiatives …
Mar 8, 2023 The Company is exiting operations in Canada and considers these operations discontinued. For more information, please visit www.imcannabis.com. Company Contact: …See details»
About - IMCannabis
Matching The Medical Cannabis Strain to The Patient’s Specific Needs & Condition “Establishing the right strain and dosage is a combination of science and art, both guided by the principal of advancing slowly, while monitoring the …See details»
IM Cannabis Announces Plans to Voluntarily Delist from the …
5 days ago [email protected] Oren Shuster, CEO IM Cannabis Corp. +972-77-3603504 [email protected]. Author: Zheng-Yi Ong Created Date: 5/28/2025 10:00:03 AM ...See details»
IM Cannabis - Crunchbase Company Profile & Funding
IM Cannabis produces and distributes medical cannabis. Its products include products for patients and offer research and development of new genetic strains.See details»
IMCC - IM Cannabis Corp. | Company Profile | OTC Markets
Mar 21, 2025 IMCC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, …See details»
IM Cannabis Announces Additional Restructuring Initiatives
Mar 8, 2023 The Company aims for a leaner organization with a primary focus on achieving profitability in 2023 and approximately CAD$3.5 million in annualized cost savings . …See details»
IM Cannabis Corp. (IMCC)
May 15, 2025 [email protected]. Investor Relations. Oren Shuster, CEO IM Cannabis Corp. T: +972-77-3603504 [email protected]. Anna Taranko, Director Investor & Public …See details»
IMCannabis
DAIRY QUEEN (DQ) This rich, velvety strain has a cherry aroma and was named after its smooth texture, which resembles ice-cream. It reduces stress and provides a calm, relaxed feeling …See details»
IM Cannabis Announces Plans to Voluntarily Delist from the …
5 days ago TORONTO and GLIL YAM, Israel, May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis …See details»
IM Cannabis Corp. | The Canadian Securities Exchange (CSE)
Imcannabis.com. IMCC is an international medical cannabis company, and a well-known Israeli brand of medical cannabis products. In Europe, IMCC is establishing a fully operational, …See details»
IM Cannabis Announces Intention to Complete Consolidation
Jul 5, 2024 IM Cannabis Corp. Logo. The Board has set July 12, 2024 as the effective date of the Consolidation and anticipates the Common Shares to trade on a post-consolidated basis …See details»
IM Cannabis Announces Filing of Information Circular for …
May 7, 2025 TORONTO and GLIL YAM, Israel, May 7, 2025 /CNW/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the "Company" or "IM Cannabis "), a leading medical cannabis …See details»
IM Cannabis Announces Filing of Information Circular for …
May 7, 2025 TORONTO and GLIL YAM, Israel, May 7, 2025 /CNW/ -- IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis …See details»
IM Cannabis Provides Corporate Updates
6 days ago For further information, or to obtain copies of the Early Warning Reports, please contact the Acquirors by emailing [email protected] or calling +972 542815033. …See details»
Home - IMCannabis
Knowledge. Technology. High-Quality Medical Cannabis. As a leading company approved by the MOH for the past decade, IMC works tirelessly to allow our patients to live a happy & fulfilling life.See details»
IM Cannabis to Focus on Israel, German and European Growth; …
With this move, the Company aims for a leaner organization with a primary focus on achieving profitability in 2023. IMC will continue building on the increasing demand and positive …See details»
IM Cannabis Announces Plans to Voluntarily Delist from the …
5 days ago IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary …See details»
IM Cannabis Provides Corporate Updates - Newswire
6 days ago Further to its press releases dated Aprill 11, 2025 (the "April 11 Release") and May 7, 2025 (the "May 7 Release"), the Company is pleased to announce results of its annual …See details»
Press Releases :: IM Cannabis Corp. (IMCC)
Mar 31, 2025 chevron_left imcannabis.com; Press Releases. News & Events . News & Events. Press Releases; Events & Presentations; Email Alerts; Year. Category. May 28, 2025 8:00am …See details»
IM Cannabis Provides Corporate Updates
Apr 11, 2025 [email protected] [1] The Company reported stockholders' equity of $3,146,000 in Canadian Dollars. On December 31, 2024, the indicative rate of exchange for …See details»